Treatment with 20 mg Revatio (sildenafil) three times a day may be more effective than lower dosages, a clinical…
Articles by Joana Fernandes, PhD
Infants, newborns and children with pulmonary hypertension (PH) can be safely and effectively treated with phosphodiesterase type 5 (PDE-5) inhibitors,…
Older age and abnormal oxygen-carbon monoxide blood levels may lead to poorer survival in patients with systemic sclerosis (SSc) and pulmonary…
Patients with pulmonary arterial hypertension (PAH) have low levels of low-density lipoprotein cholesterol (LDL-C) – or “bad cholesterol” – which…
A patient treated with chemotherapy and radiation after breast cancer surgery developed pulmonary hypertension and other heart complications, according to…
Training with an oscillatory whole-body vibration (WBV) device may improve the exercise capacity, physical performance and quality of life of…
In a Phase 3 clinical trial, Opsumit (macitentan) did not meet the study’s primary goal — improved exercise capacity —…
Women with high-risk congenital heart disease can safely become pregnant and give birth if they are carefully monitored and managed by…
Almost one-fourth of pulmonary arterial hypertension (PAH) patients in a small recent study had pulmonary artery aneurysm (PAA), a condition…
The U.S. Food and Drug Administration (FDA) accepted several modifications proposed by Bellerophon Therapeutics for its Phase 3 program…
The specific benefits of balloon pulmonary angioplasty (BPA) on the respiratory function of patients with chronic thromboembolic pulmonary hypertension (CTEPH)…
The hardships felt by caregivers of patients with pulmonary arterial hypertension (PAH) are “multidimensional” — emotional, physical and economic — and those burdens should…